Format

Send to:

Choose Destination
See comment in PubMed Commons below
Pediatr Infect Dis J. 2004 Feb;23(2 Suppl):S135-9.

Safety and tolerability of azithromycin in pediatric infectious diseases: 2003 update.

Author information

  • 1Department of Pediatrics, Turku University Hospitals, Turku, Finland. olli.ruuskanen@tyks.fi

Abstract

Oral azithromycin suspension has been prescribed to >80 million patients. Children find the color and taste of the oral suspension of azithromycin agreeable, and the drug is well-tolerated. On average 9% of patients have treatment-related adverse events, which are most frequently gastrointestinal complaints. The side effects are mild to moderate and very seldom necessitate withdrawal of the treatment. In addition to the conventional 3-day 10-mg/kg/day regimen and the 10 mg/kg on Day 1 followed by 5 mg/kg on Days 2 to 5 regimens, single dose 30 mg/kg and 3-day 20-mg/kg/day regimens are well-tolerated, although these new dosages are associated with more adverse effects.

PMID:
14770077
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Write to the Help Desk